Access 2.8M+ Filings Sign Up Free
AcuCort AB Logo

AcuCort AB | ACUC - Profile, Filings, Stock Info & Investor Relations Data

AcuCort AB | ACUC
Filings & Investor Relations Data
Login to Watchlist

Create a free account or log in.

Industry
Biotechnology
Country
Sweden
Founded
N/A
AcuCort AB (ACUC)

Company Profile

Website
Investor Relations

About AcuCort AB

AcuCort is a pharmaceutical company. The company has developed and commercializes the drug Zeqmelit®, which is an oral film based on the cortisone substance dexamethasone, for quick availability and relief in severe and acute allergic reactions, among other things. The goal is commercialization in the EU, USA and in selected key markets via licensees and distributors. The company has its headquarters in Lund.

Headquarters

Scheeletorget 1
223 81, Lund
Sweden

AcuCort AB (ACUC)
Key Financial Data

AI-Powered Financial Insights Coming Soon

We are currently processing the filings for this company to provide automated financial statement analysis, key ratios, and risk summaries. Please check back later!

Unlock Full Company Insights & AI Chat

Create a free account or log in to add companies to your watchlist, access more data, and chat directly with filings using our AI assistant (as shown!).

Create Free Account Sign In

AcuCort AB (ACUC)
Filings & Annual Reports
Chat with AI, summarize, and extract data from processed filings! Look for the 'View & AI' button.

Quick Filters:

Advanced Filters

View all types
Filing Information Actions

Insider Trading Activity

↑
Ebba Cecilia Fåhraeus (Other)
Buy SEK 81,900.00 SEK 0.90 24.01.25

AcuCort AB (ACUC)
Stock & Investor Information

ISINs

SE0009695927

LEI

54930087FR3VVW5SU676

Stock Exchange Listings

Spotlight Exchange

Industry Classification

Sector
Health Care
Industry
Biotechnology